- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Accera, Inc.
Total 35918 results
-
Ocera TherapeuticsTerminatedGastroesophageal Reflux Disease (GERD)United States
-
Ocera TherapeuticsTerminatedPouchitisUnited States
-
Avera PharmaceuticalsTerminatedOveractive Bladder SyndromeNetherlands, United Kingdom
-
AccurxLindus HealthCompletedAsthma | COPDUnited Kingdom
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States, Italy, Spain, United Kingdom, Belgium, Denmark, Hungary, Poland, Australia, Germany, Israel, Netherlands, Turkey, France, New Zealand
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited Kingdom, Poland
-
Acerta Pharma BVCompletedHealthy ParticipantsUnited States
-
Acerta Pharma BVTerminatedDLBCL | Richter SyndromeUnited Kingdom, United States
-
Acerta Pharma BVCompletedRheumatoid ArthritisUnited States
-
Athera Biotechnologies ABTerminatedCardiovascular Diseases | Arterial InflammationSweden, Netherlands
-
Access Business GroupCompletedHyperlipidemiaUnited States
-
Access Business GroupCompleted
-
Ash Access TechnologyUnknown
-
Universidad Autónoma de EncarnaciónUniversity of Valencia; Adhera Health, Inc.CompletedQuality of Life | Stress | Emotional AdjustmentParaguay
-
Akcea TherapeuticsRecruitingHereditary Transthyretin Amyloidosis With PolyneuropthyUnited States, Canada
-
Ocera TherapeuticsCompletedMild Hepatic EncephalopathyUnited States
-
Ocera TherapeuticsCompletedIrritable Bowel SyndromeUnited States, Belgium
-
Ocera TherapeuticsCompletedIntestinal Fistula | Inflammatory Bowel DiseaseUnited States, Israel, Canada, United Kingdom, Germany, Belgium, Hungary, France, Austria, Czech Republic, Netherlands, Poland
-
Ocera TherapeuticsCompletedHepatic EncephalopathyUnited States
-
Avera PharmaceuticalsCompletedSocial PhobiaUnited States
-
Integrative Skin Science and ResearchActeraNot yet recruitingHyperpigmentation | Acne | Post-inflammatory Hyperpigmentation
-
Integrative Skin Science and ResearchActeraActive, not recruiting
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter's SyndromeUnited States, United Kingdom, Italy
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States, United Kingdom, Belgium, Spain, Israel, France
-
Acerta Pharma BVActive, not recruitingMantle Cell Lymphoma (MCL)Belgium, France, United Kingdom, United States, Italy, Poland, Netherlands, Australia, Czechia, Spain
-
Acerta Pharma BVCompletedA Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196Healthy ParticipantsUnited States
-
Athera Biotechnologies ABCompletedST Elevation Myocardial InfarctionSweden
-
Acerta Pharma BVCompletedHealthy VolunteersUnited States
-
Access Business GroupCompletedGut MicrobiomeUnited States
-
Vital Access Corp.CompletedEnd Stage Renal Disease | Kidney Failure | AV FistulaUnited States
-
Acerta Pharma BVWithdrawn
-
American Access CareUnknownHemodialysisUnited States
-
Access Business GroupCompleted
-
Adhera Health, Inc.Novo Nordisk A/S; Hospital Miguel ServetCompletedDiabetes Mellitus, Type 1Spain
-
Till BärnighausenClinton Health Access Initiative Inc.Completed
-
Clinton Health Access Initiative Inc.UNICEF; Ministry of Health, MalawiCompleted
-
Avera McKennan Hospital & University Health CenterCellworks Group Inc.Recruiting
-
Acerta Pharma BVAstraZenecaActive, not recruitingChronic Lymphocytic LeukemiaUnited States, Spain, Canada, Italy, Taiwan, Russian Federation, Turkey, Germany, Korea, Republic of, Brazil, Hungary, Poland, China, Sweden, Bulgaria, Israel, United Kingdom, Australia, Saudi Arabia, Austria, France, Czechia, South... and more
-
Acerta Pharma BVAstraZenecaActive, not recruitingLymphoma, Mantle CellUnited States, France, Italy, Taiwan, Mexico, Russian Federation, Vietnam, Belgium, Canada, Brazil, Hungary, Japan, Poland, China, Spain, Germany, Australia, Czechia, Korea, Republic of, Israel, Romania, Ukraine, Argentina, Peru, New Zealand and more
-
Acerta Pharma BVAstraZenecaTerminated
-
AstraZenecaAcerta Pharma BVCompletedCOVID-19Italy, Turkey, Brazil, Japan, South Africa, Germany, Poland, Russian Federation, India, Peru, France, Argentina, Chile, Mexico
-
AstraZenecaAcerta Pharma BVCompleted
-
Accuray IncorporatedStanford UniversityWithdrawnRecurrent Hepatocellular CarcinomaUnited States
-
Acer Medical Inc.National Taiwan University HospitalCompletedMacular Degeneration, Age Related | Maculopathy, Age RelatedTaiwan
-
Akcea TherapeuticsRecruitingPregnancy | Hereditary Transthyretin-mediated Amyloidosis With PolyneropathyUnited States
-
Akcea TherapeuticsCompletedCardiovascular Diseases | Elevated Lipoprotein(a)Canada
-
Akcea TherapeuticsCompletedCardiovascular Diseases | Elevated Lipoprotein(a)Canada
-
Ocera TherapeuticsCompleted
-
Avera PharmaceuticalsCompleted